Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Report 2017

去勢抵抗性前立腺癌(CRPC)治療の世界市場

◆タイトル:Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Report 2017
◆商品コード:QYR70900985
◆調査・発行会社:QYResearch
◆発行日:2017年7月11日
◆ページ数:109
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・ヘルスケア
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

QYResearchが発行した当調査レポートでは、世界の去勢抵抗性前立腺癌(CRPC)治療市場について調査・分析し、去勢抵抗性前立腺癌(CRPC)治療の世界市場概観、去勢抵抗性前立腺癌(CRPC)治療の種類別市場分析、用途別市場分析、去勢抵抗性前立腺癌(CRPC)治療の世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・去勢抵抗性前立腺癌(CRPC)治療の世界市場概観
・去勢抵抗性前立腺癌(CRPC)治療の種類別市場規模
・去勢抵抗性前立腺癌(CRPC)治療の用途別市場規模
・去勢抵抗性前立腺癌(CRPC)治療の世界市場規模
・去勢抵抗性前立腺癌(CRPC)治療の世界市場規模予測
・去勢抵抗性前立腺癌(CRPC)治療の主要地域別市場規模
・去勢抵抗性前立腺癌(CRPC)治療の北米市場規模・予測
・去勢抵抗性前立腺癌(CRPC)治療のヨーロッパ市場規模・予測
・去勢抵抗性前立腺癌(CRPC)治療の中国市場規模・予測
・去勢抵抗性前立腺癌(CRPC)治療の日本市場規模・予測
・去勢抵抗性前立腺癌(CRPC)治療のアジア市場規模・予測
・去勢抵抗性前立腺癌(CRPC)治療の製造メーカー分析
・去勢抵抗性前立腺癌(CRPC)治療のメーカー別生産量
・去勢抵抗性前立腺癌(CRPC)治療のメーカー別市場シェア
・去勢抵抗性前立腺癌(CRPC)治療の価格動向・価格分析
・去勢抵抗性前立腺癌(CRPC)治療の販売(売上高)動向
・去勢抵抗性前立腺癌(CRPC)治療の貿易(輸出・輸入)動向
・去勢抵抗性前立腺癌(CRPC)治療の産業チェーン分析
・去勢抵抗性前立腺癌(CRPC)治療のマーケティング戦略分析
・去勢抵抗性前立腺癌(CRPC)治療の販売業者(代理店)リスト
・去勢抵抗性前立腺癌(CRPC)治療の市場環境分析
...

In this report, the global Castration-Resistant Prostate Cancer (CRPC) Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Castration-Resistant Prostate Cancer (CRPC) Treatment in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Castration-Resistant Prostate Cancer (CRPC) Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Astellas Pharma
Johnson & Johnson
Sanofi
Valeant
Dendreon
Bayer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiotherapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Castration-Resistant Prostate Cancer (CRPC) Treatment for each application, including
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Report 2017
1 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Overview
1.1 Product Overview and Scope of Castration-Resistant Prostate Cancer (CRPC) Treatment
1.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Segment by Type (Product Category)
1.2.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share by Type (Product Category) in 2016
1.2.3 Chemotherapy
1.2.4 Hormonal Therapy
1.2.5 Immunotherapy
1.2.6 Radiotherapy
1.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Segment by Application
1.3.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market by Region (2012-2022)
1.4.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Castration-Resistant Prostate Cancer (CRPC) Treatment (2012-2022)
1.5.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Status and Outlook (2012-2022)
1.5.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production Status and Outlook (2012-2022)

2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Competition by Manufacturers
2.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production and Share by Manufacturers (2012-2017)
2.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Share by Manufacturers (2012-2017)
2.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Castration-Resistant Prostate Cancer (CRPC) Treatment Manufacturing Base Distribution, Sales Area and Product Type
2.5 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Competitive Situation and Trends
2.5.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Concentration Rate
2.5.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity and Market Share by Region (2012-2017)
3.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production and Market Share by Region (2012-2017)
3.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption by Region (2012-2017)
4.2 North America Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export, Import (2012-2017)
4.3 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export, Import (2012-2017)
4.4 China Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export, Import (2012-2017)
4.5 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export, Import (2012-2017)
4.7 India Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export, Import (2012-2017)

5 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue (Value), Price Trend by Type
5.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production and Market Share by Type (2012-2017)
5.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Market Share by Type (2012-2017)
5.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price by Type (2012-2017)
5.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth by Type (2012-2017)

6 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Analysis by Application
6.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption and Market Share by Application (2012-2017)
6.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Manufacturers Profiles/Analysis
7.1 Astellas Pharma
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Sanofi
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Valeant
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Dendreon
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Bayer
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Castration-Resistant Prostate Cancer (CRPC) Treatment Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview

8 Castration-Resistant Prostate Cancer (CRPC) Treatment Manufacturing Cost Analysis
8.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Castration-Resistant Prostate Cancer (CRPC) Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Castration-Resistant Prostate Cancer (CRPC) Treatment Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Forecast (2017-2022)
12.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price and Trend Forecast (2017-2022)
12.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Castration-Resistant Prostate Cancer (CRPC) Treatment
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Chemotherapy
Table Major Manufacturers of Chemotherapy
Figure Product Picture of Hormonal Therapy
Table Major Manufacturers of Hormonal Therapy
Figure Product Picture of Immunotherapy
Table Major Manufacturers of Immunotherapy
Figure Product Picture of Radiotherapy
Table Major Manufacturers of Radiotherapy
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Unit) by Applications (2012-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Market Share by Applications in 2016
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Size (Million USD), Comparison (Unit) and CAGR (%) by Regions (2012-2022)
Figure North America Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit) Status and Outlook (2012-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Major Players Product Capacity (Unit) (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity (Unit) of Key Manufacturers (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity (Unit) of Key Manufacturers in 2016
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity (Unit) of Key Manufacturers in 2017
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Major Players Product Production (Unit) (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) of Key Manufacturers (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Share by Manufacturers (2012-2017)
Figure 2016 Castration-Resistant Prostate Cancer (CRPC) Treatment Production Share by Manufacturers
Figure 2017 Castration-Resistant Prostate Cancer (CRPC) Treatment Production Share by Manufacturers
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Major Players Product Revenue (Million USD) (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Share by Manufacturers
Table 2017 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Share by Manufacturers
Table Global Market Castration-Resistant Prostate Cancer (CRPC) Treatment Average Price (K USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Castration-Resistant Prostate Cancer (CRPC) Treatment Average Price (K USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Castration-Resistant Prostate Cancer (CRPC) Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Castration-Resistant Prostate Cancer (CRPC) Treatment Product Category
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Market Share of Top 3 Manufacturers
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Market Share of Top 5 Manufacturers
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity (Unit) by Region (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity Market Share by Region (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity Market Share by Region (2012-2017)
Figure 2016 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity Market Share by Region
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production by Region (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) by Region (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share by Region (2012-2017)
Figure 2016 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share by Region
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) by Region (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share by Region (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share by Region (2012-2017)
Table 2016 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share by Region
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit) and Growth Rate (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table North America Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table China Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table India Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Unit) Market by Region (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Market Share by Region (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Market Share by Region (2012-2017)
Figure 2016 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Unit) Market Share by Region
Table North America Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Import & Export (Unit) (2012-2017)
Table Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Import & Export (Unit) (2012-2017)
Table China Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Import & Export (Unit) (2012-2017)
Table Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Import & Export (Unit) (2012-2017)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Import & Export (Unit) (2012-2017)
Table India Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Import & Export (Unit) (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) by Type (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Share by Type (2012-2017)
Figure Production Market Share of Castration-Resistant Prostate Cancer (CRPC) Treatment by Type (2012-2017)
Figure 2016 Production Market Share of Castration-Resistant Prostate Cancer (CRPC) Treatment by Type
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) by Type (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Castration-Resistant Prostate Cancer (CRPC) Treatment by Type (2012-2017)
Figure 2016 Revenue Market Share of Castration-Resistant Prostate Cancer (CRPC) Treatment by Type
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price (K USD/Unit) by Type (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth by Type (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Unit) by Application (2012-2017)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Market Share by Application (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Market Share by Applications (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Market Share by Application in 2016
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Growth Rate by Application (2012-2017)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Growth Rate by Application (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth Rate (2012-2017)
Figure Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share (2012-2017)
Figure Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth Rate (2012-2017)
Figure Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share (2012-2017)
Figure Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth Rate (2012-2017)
Figure Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share (2012-2017)
Figure Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share (2012-2017)
Table Valeant Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth Rate (2012-2017)
Figure Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share (2012-2017)
Figure Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share (2012-2017)
Table Dendreon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth Rate (2012-2017)
Figure Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share (2012-2017)
Figure Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Production Growth Rate (2012-2017)
Figure Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share (2012-2017)
Figure Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Castration-Resistant Prostate Cancer (CRPC) Treatment
Figure Manufacturing Process Analysis of Castration-Resistant Prostate Cancer (CRPC) Treatment
Figure Castration-Resistant Prostate Cancer (CRPC) Treatment Industrial Chain Analysis
Table Raw Materials Sources of Castration-Resistant Prostate Cancer (CRPC) Treatment Major Manufacturers in 2016
Table Major Buyers of Castration-Resistant Prostate Cancer (CRPC) Treatment
Table Distributors/Traders List
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Capacity, Production (Unit) and Growth Rate Forecast (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price (Million USD) and Trend Forecast (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) Forecast by Region (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production Market Share Forecast by Region (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Unit) Forecast by Region (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption Market Share Forecast by Region (2017-2022)
Figure North America Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) and Growth Rate Forecast (2017-2022)
Figure North America Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export and Import (Unit) Forecast (2017-2022)
Figure Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) and Growth Rate Forecast (2017-2022)
Figure Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export and Import (Unit) Forecast (2017-2022)
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) and Growth Rate Forecast (2017-2022)
Figure China Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export and Import (Unit) Forecast (2017-2022)
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) and Growth Rate Forecast (2017-2022)
Figure Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export and Import (Unit) Forecast (2017-2022)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export and Import (Unit) Forecast (2017-2022)
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) and Growth Rate Forecast (2017-2022)
Figure India Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Castration-Resistant Prostate Cancer (CRPC) Treatment Production, Consumption, Export and Import (Unit) Forecast (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) Forecast by Type (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Production (Unit) Forecast by Type (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue Market Share Forecast by Type (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price Forecast by Type (2017-2022)
Table Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Unit) Forecast by Application (2017-2022)
Figure Global Castration-Resistant Prostate Cancer (CRPC) Treatment Consumption (Unit) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[去勢抵抗性前立腺癌(CRPC)治療の世界市場] (Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Report 2017 / QYR70900985)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆